| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.800 | None | 0.833 | 1 | 1 | 2007 | 2018 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.500 | None | 1.000 | 6 | 7 | 2008 | 2020 | ||||||||
|
cholinergic receptor nicotinic beta 4 subunit | 0.644 | 0.423 | 0.14 |
|
disease | 0.500 | None | 1.000 | 4 | 13 | 2008 | 2018 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.500 | None | 0.978 | 4 | 2 | 2008 | 2019 | ||||||||
|
tumor protein p63 | 0.362 | 0.769 | 1.00 |
|
disease | 0.500 | None | 0.958 | 3 | 2 | 1999 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.500 | None | 0.934 | 1 | 2 | 2008 | 2018 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 2000 | 2017 | ||||||||
|
flap structure-specific endonuclease 1 | 0.550 | 0.731 | 4.8E-05 |
|
disease | 0.490 | None | 0.800 | 1 | 1 | 2003 | 2019 | ||||||||
|
RAD52 homolog, DNA repair protein | 0.610 | 0.654 | 7.1E-11 |
|
disease | 0.450 | None | 1.000 | 1 | 1 | 2008 | 2018 | ||||||||
|
hydroxylysine kinase | 0.769 | 0.346 | 7.3E-06 |
|
disease | 0.190 | None | 1.000 | 7 | 2 | 2008 | 2017 | ||||||||
|
iron responsive element binding protein 2 | 0.619 | 0.577 | 1.00 |
|
disease | 0.170 | None | 1.000 | 3 | 4 | 2008 | 2020 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.160 | None | 1.000 | 1 | 1 | 1998 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.140 | None | 1.000 | 3 | 3 | 1994 | 2017 | ||||||||
|
mutS homolog 5 | 0.641 | 0.692 | 3.2E-11 |
|
disease | 0.120 | None | 0.800 | 3 | 1 | 2008 | 2017 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.120 | None | 1.000 | 2 | 1 | 2009 | 2017 | ||||||||
|
HORMA domain containing 2 | 0.716 | 0.385 | 7.1E-05 |
|
disease | 0.120 | None | 1.000 | 1 | 18 | 2011 | 2014 | ||||||||
|
apolipoprotein M | 0.590 | 0.769 | 9.6E-04 |
|
disease | 0.110 | None | 1.000 | 3 | 1 | 2008 | 2018 | ||||||||
|
zinc ribbon domain containing 1 | 0.653 | 0.654 | 0.21 |
|
disease | 0.110 | None | 1.000 | 2 | 1 | 2009 | 2016 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.110 | None | 1.000 | 2 | 1 | 2008 | 2019 | ||||||||
|
myotubularin related protein 3 | 0.682 | 0.462 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 19 | 2011 | 2011 | ||||||||
|
zinc ribbon domain containing 1 antisense, pseudogene | 0.691 | 0.538 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2012 | 2016 | |||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2012 | 2015 | ||||||||
|
discoidin, CUB and LCCL domain containing 1 | 0.729 | 0.231 | 6.3E-08 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||
|
MSH5-SAPCD1 readthrough (NMD candidate) | 0.760 | 0.423 |
|
disease | 0.100 | None | 1.000 | 3 | 1 | 2008 | 2012 | |||||||||
|
major histocompatibility complex, class II, DQ alpha 2 | 0.617 | 0.769 | 1.0E-05 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2009 | 2012 |